• CORMCO's mission is to deploy patient capital and generate superior long-term investment returns while embracing stringent risk management methodologies.

    Our public equity portfolio applies a fundamentally oriented and long-term investment approach. We invest in tech, biotech, and real estate companies that benefit from powerful secular growth trends, strong management teams, and impeccable financials statments.

     

    Our private equity portfolio invests in tech, biotech, and real estate growth companies already backed by solid institutional funding, including investments ranging from Series C to pre-IPO.

     

    CORMCO emphasizes risk management, which is reflected in its asset allocation strategies. It encourages diversification by investing in different asset classes and industry subsectors to manage systematic risk and reduce the impact of market fluctuations.